carboplatin-Taxol-bevacizumab regimen
(KAR-boh-pla-tin-TAK-sol-beh-vuh-SIH-zoo-mab REH-jih-men)
A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-paclitaxel-bevacizumab regimen.